PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40180682,Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial.,2025,Michael Ryan; Lawrence Gervasi; Mike Ufer; Yi Zhong; James D'Olimpio,Pfizer Inc.; Sumitomo Pharma America Inc.; SouthWest Urology LLC; Sumitomo Pharma Switzerland GmbH; Clinical Research Alliance,Jose.DeLaCerda@urologysa.com.
40174256,"A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™.",2025,Sai D Prasad; Krishna Mohan Vadrevu; Raches Ella; Siddharth Reddy; Brunda Ganneru; Bhargav Reddy; Badri Patnaik,Bharat Biotech International Limited,kmohan@bharatbiotech.com.
